Rachel Presti, MD, PhD, an infectious disease physician who led WashU Med’s participation in the Johnson & Johnson/Janssen COVID-19 vaccine trial, encourages the public to take the first vaccine available to them. Presti’s team conducted their clinical trial for several months — as the St. Louis area saw massive spikes in COVID-19 cases — and […]
Comparison of Blood (1->3)-β-D-Glucan Levels in AIDS-Related Pneumocystis jirovecii Pneumonia and AIDS-Related Progressive Disseminated Histoplasmosis. Michael Saccente, Gayathri Krishnan. Clinical Infectious Diseases, ciab277, https://doi.org/10.1093/cid/ciab277. Relevance: Beta D glucan is a noninvasive test used for diagnosis of fungal infections and is helpful in patients with immunosuppressed conditions. Dr. Krishnan et al also published a case report in the Arkansas […]
Miguel Chavez Concha, MD, MSc, first year fellow, is a 2021 recipient of the Jonathan Freeman Scholarship. The award is was established by SHEA to promote the training of outstanding infectious disease fellows who demonstrate interest in the field of healthcare epidemiology. The award is intended to support infection control professionals’ scholarly activities in hospital […]
The virus had not yet left Wuhan, China, when the School of Medicine, Barnes-Jewish Hospital and BJC HealthCare started bracing for a medical disaster of greater magnitude than any they had ever experienced. Six weeks before COVID-19 reached St. Louis, incident command centers were set up at every BJC hospital, with a joint incident command […]
Please come and join us for our inaugural event for Latinx faculty and staff meant for those on the Danforth and Med campus! The first 15 to register will be able to select a lunch option from Fritanga. ¡Salud! Register here. If you have any questions, please contact Julia López, PhD, MPH, LCSW, instructor in […]
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or […]
The FDA has confirmed a third vaccine is effective and safe in protecting against COVID-19. The vaccine, manufactured by Johnson & Johnson, is overall 67% effective beginning 14 days after vaccination, 77% effective against severe illness and completely effective against death from COVID-19. Efficacy increased over time and was demonstrated against more infectious variants seen in […]
A 2011 report by WHO found UTIs contributed to over 8 million office visits and over 1 million hospitalizations, for an overall annual cost of over $1 billion.
Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean and President for Academic Affairs at Mount Sinai Health System announced that Judith Aberg, MD, the Dr. George Baehr Professor of Clinical Medicine, has been appointed Dean of System Operations for Clinical Sciences at the Icahn School of Medicine at Mount Sinai. An internationally renowned […]
Washington University School of Medicine announces a new clinical trial for COVID-19 positive patients, STOP COVID Trial. Many patients testing positive for COVID-19 initially experience mild symptoms, but then clinically deteriorate in the second week of illness. The STOP COVID Trial tests a medication (fluvoxamine) for its anti-COVID properties for individuals ages 30 and up […]
Use of viruses to target tumors has a long history. ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 21 with Sharmila Nair, PhD, an instructor in Infectious Diseases, about her recent work to understand the oncolytic activity of Zika virus for a fatal human cancer, Glioblastoma […]
Of the nine treatments and preventives for COVID-19 authorized for emergency use by the Food and Drug Administration, three are drugs made from so-called monoclonal antibodies. Such drugs provide patients with ready-made antibodies that neutralize the virus, bypassing the body’s slower and sometimes less effective process of making its own antibodies. But such therapies were […]
The antidepressant fluvoxamine shows promise in preventing people infected with coronavirus from developing serious symptoms and having to be hospitalized, according to a nonrandomized study of California racetrack workers.
Highlighting members during Black History Month This Black History Month, the IDSA Foundation highlighted members that make this month even more special. While Black History Month is only one month, the IDSA Foundation focuses year-round on diversity and inclusion for the future of ID. In the video below, Dr. Mati Hlatshwayo Davis shares her thoughts […]
Treatment for HIV has improved tremendously over the past 30 years; once a death sentence, the disease is now a manageable lifelong condition in many parts of the world. Life expectancy is about the same as that of individuals without HIV, though patients must adhere to a strict regimen of daily antiretroviral therapy, or the […]
‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 20 with Tristan Jordan, PhD, a postdoctoral scholar at the Icahn School of Medicine at Mount Sinai in New York City, about his work using a CRISPR screen and proteomics of the virus replication complex to identify new […]
“If we don’t make it plain, we’re never going to address it or get through it” For a few days after May 16, 2020, Dr. Matifadza Hlatshwayo Davis was in a safe space or so she thought.
Global campaigns to eliminate two tropical parasitic worm infections have been hindered by lack of good diagnostic tools. Since the turn of the century, multinational mass drug-treatment efforts have cut the number of people at risk of lymphatic filariasis and onchocerciasis by more than half, but more than half a billion people remain at risk. […]
Meet the people behind today’s virology headlines. People just like you working to understand viruses and how they affect you. ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 19 with Rachel Presti, MD/PhD, an associate professor of Medicine and the medical director of the Infectious Diseases […]